Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dhindsa

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Nature|August 10, 2021
Rare variant contribution to human disease in 281,104 UK Biobank exomesQuanli Wang, Ryan S Dhindsa, Keren Carss, et al.
Science Signaling|May 10, 2022
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signalingChirag Vasavda, Evan R Semenza, Jason Liew, et al.
The American Journal of Cardiology|November 6, 2017
Relation of Changes in Body Fat Distribution to Oxidative StressHeval M Kelli, Frank E Corrigan, Robert E Heinl, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr Virus infectionSherry S Nyeo, Erin M Cumming, Oliver S Burren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2021
Vascular Regenerative Capacity and the Obesity Paradox in Coronary Artery DiseaseAnurag Mehta, Qi Meng, Xiaona Li, et al.
International Journal of Cardiology|December 2, 2022
Circulating progenitor cells and outcomes in patients with coronary artery diseaseDevinder S Dhindsa, Shivang R Desai, Qingchun Jin, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
Nature|January 28, 2026
Population-scale sequencing resolves determinants of persistent EBV DNASherry S Nyeo, Erin M Cumming, Oliver S Burren, et al.
Contemporary Clinical Trials|March 8, 2020
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) studyAnurag Mehta, Kreton Mavromatis, Yi-An Ko, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Nature|August 10, 2021
Rare variant contribution to human disease in 281,104 UK Biobank exomesQuanli Wang, Ryan S Dhindsa, Keren Carss, et al.
Science Signaling|May 10, 2022
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signalingChirag Vasavda, Evan R Semenza, Jason Liew, et al.
The American Journal of Cardiology|November 6, 2017
Relation of Changes in Body Fat Distribution to Oxidative StressHeval M Kelli, Frank E Corrigan, Robert E Heinl, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr Virus infectionSherry S Nyeo, Erin M Cumming, Oliver S Burren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2021
Vascular Regenerative Capacity and the Obesity Paradox in Coronary Artery DiseaseAnurag Mehta, Qi Meng, Xiaona Li, et al.
International Journal of Cardiology|December 2, 2022
Circulating progenitor cells and outcomes in patients with coronary artery diseaseDevinder S Dhindsa, Shivang R Desai, Qingchun Jin, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
Nature|January 28, 2026
Population-scale sequencing resolves determinants of persistent EBV DNASherry S Nyeo, Erin M Cumming, Oliver S Burren, et al.
Contemporary Clinical Trials|March 8, 2020
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) studyAnurag Mehta, Kreton Mavromatis, Yi-An Ko, et al.
Pageof 21